Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Meningococcal Immunisation (Healthy Volunteers)”

23 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 23 results

Not applicableEnded earlyNCT03549325
What this trial is testing

A Study Assessing Colonisation & Immunogenicity After Nasal Inoculation With N. Lactamica and Eradication on Day 4 or 14

Who this might be right for
Meningitis, Meningococcal
University Hospital Southampton NHS Foundation Trust 21
Large-scale testing (Phase 3)Study completedNCT04142242
What this trial is testing

Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine in Older Adults Who Received a Primary Vaccination (3 or More Years Earlier) in Study MET49

Who this might be right for
Meningococcal Infection (Healthy Volunteers)
Sanofi Pasteur, a Sanofi Company 471
Large-scale testing (Phase 3)Study completedNCT04084769
What this trial is testing

Study to Evaluate the Immune Response After a Booster Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine When Administered Alone or Concomitantly With a Licensed Meningococcal Serogroup B Vaccine, in Participants Who Received Primary Quadrivalent Meningococcal Conjugate Vaccine (MCV4)

Who this might be right for
Meningococcal Immunisation (Healthy Volunteers)
Sanofi Pasteur, a Sanofi Company 570
Testing effectiveness (Phase 2)Study completedNCT00137917
What this trial is testing

Immunogenicity & Safety Study of a Meningococcal Serogroup B Vaccine Given in a 3 Dose Schedule to Healthy Adolescents Aged 12-18 Yrs

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 478
Testing effectiveness (Phase 2)Active Not RecruitingNCT06647407
What this trial is testing

Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants

Who this might be right for
Meningococcal ImmunizationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 750
Testing effectiveness (Phase 2)Study completedNCT00126945
What this trial is testing

Evaluate 4 Different Formulations of Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 125
Large-scale testing (Phase 3)Study completedNCT06284915
What this trial is testing

Study on Immunogenicity and Safety of a Meningococcal ACYW Conjugate Vaccine in Healthy Infants and Toddlers

Who this might be right for
Meningococcal ImmunisationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 840
Large-scale testing (Phase 3)Study completedNCT01777308
What this trial is testing

Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine Administered 6 Years Post-MenC Primary Vaccination in Healthy Subjects Who Were 12-18 Months at Primary Vaccination

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 156
Large-scale testing (Phase 3)Active Not RecruitingNCT04936685
What this trial is testing

Study on an Investigational Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Administered as a 5- and/or 10-year Booster Doses in Children and Adolescents Vaccinated 5 or 10 Years Earlier as Toddlers

Who this might be right for
Meningococcal ImmunisationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 209
Testing effectiveness (Phase 2)Study completedNCT00780806
What this trial is testing

Safety And Blood Collection Study Of Meningococcal B Rlp2086 Vaccine In Adults

Who this might be right for
Meningitis, Meningococcal
Wyeth is now a wholly owned subsidiary of Pfizer 60
Early research (Phase 1)Ended earlyNCT04825223
What this trial is testing

Study of a Novel Multicomponent Meningococcal Group B Vaccine When Given Alone or With Other Licensed Vaccines in Adults, Adolescents, Toddlers and Infants

Who this might be right for
Meningococcal ImmunisationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 576
Large-scale testing (Phase 3)Study completedNCT04143061
What this trial is testing

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adults, Adolescents, Children, and Toddlers in India and Healthy Adolescents and Children in the Republic of South Africa

Who this might be right for
Meningococcal ImmunizationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 1,328
Testing effectiveness (Phase 2)Study completedNCT00661557
What this trial is testing

Comparison of GSK134612 in Subjects Previously Vaccinated Against Meningococcal Disease Versus Non-vaccinated Subjects

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 271
Testing effectiveness (Phase 2)Study completedNCT00356369
What this trial is testing

Study in Adolescents/Adults to Evaluate Non-inferiority&Persistence up to 5 Years of GSK Bio MenACWY Conjugate Vaccine

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 500
Large-scale testing (Phase 3)Study completedNCT05794230
What this trial is testing

Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa

Who this might be right for
Meningococcal ImmunisationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 1,528
Testing effectiveness (Phase 2)Study completedNCT06128733
What this trial is testing

Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents

Who this might be right for
Meningococcal ImmunisationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 1,215
Large-scale testing (Phase 3)Study completedNCT04490018
What this trial is testing

Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to a Meningococcal Reference Vaccine, and When Given Alone or With Two Other Vaccines in Healthy Adolescents

Who this might be right for
Meningococcal ImmunisationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 463
Not applicableStudy completedNCT04665791
What this trial is testing

A Human Controlled Infection Study with Neisseria Lactamica in Malian Adults

Who this might be right for
Meningitis, Meningococcal
Center for Vaccine Development - Mali 55
Large-scale testing (Phase 3)Study completedNCT02141516
What this trial is testing

Safety and Immunogenicity of Novartis Meningococcal B Vaccine When Administered to Immunocompromised Children and Adolescents Compared to Healthy Subjects.

Who this might be right for
Meningococcal Disease
Novartis 239
Large-scale testing (Phase 3)Study completedNCT04368429
What this trial is testing

Study of a Quadrivalent Meningococcal Conjugate Vaccine as a Single Dose Compared With a Single Dose of a Meningococcal Reference Vaccine in Children, Adolescents, and Adults 2 to 55 Years of Age

Who this might be right for
Meningococcal Immunisation (Healthy Volunteers)
Sanofi 360
Load More Results